Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 3

2(33.3%)

Phase 2

2(33.3%)

Phase 1

1(16.7%)

Phase 4

1(16.7%)

6Total

Phase 3(2)

Phase 2(2)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05415137Phase 3Active Not Recruiting

Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

Role: collaborator

NCT04908800Phase 1Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KRP-A218 in Healthy Subjects

Role: lead

NCT01654783Completed

Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA

Role: lead

NCT00995345Phase 2Completed

Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone

Role: collaborator

NCT00525330Phase 2Completed

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone

Role: collaborator

NCT01693471Completed

Survey on the Effect of Health Related Quality of Life (QOL) Associated With Compliance of Carbocisteine in Asthma Patients

Role: lead

NCT00512785Phase 3Completed

Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder

Role: collaborator

NCT01578304Phase 4Completed

Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder

Role: collaborator

NCT00281034Completed

OASIS STUDY Outcome Assessment Using SF-36 v2 in Stroke Patient Study(OASIS STUDY)

Role: lead

All 9 trials loaded